January 05, 2022

The Future of Due Diligence in Healthcare M&A

COVID-19 placed healthcare squarely in the center of everyone’s mind. From fledgling startups to large corporates, the healthcare industry is modernizing itself at lightning speed.

To make that happen, deal activity within healthcare has exploded at dizzying rates. R&D breakthroughs, point-of-care disruption, and strategic plays into digital health make the healthcare sector one rich with opportunity and risk. To manage that risk, staying on top of due diligence best practices is critical. In this whitepaper, we explore:

  • Current healthcare M&A due diligence benchmarks 
  • Trends reshaping the face of healthcare due diligence
  • An updated healthcare due diligence checkup list

Download the whitepaper and learn more. 

Ready to Get Started?

You may also like:

Dealmakers League: Top M&A Investment Bankers and Lawyers in 2022

Get the essential reference tool for every dealmaker, to see which investment lawyers and bankers are leading the pack in North America and EMEA. So you can ensure you have the right people on your side on your next deal.

Datasite Forecaster February Global Outlook

Check out this month's Forecaster, where we provide a quick update on where the M&A market is heading, based on aggregated and anonymized data room activity.

Deal Drivers: APAC FY 2022

APAC M&A declined in 2022, mirroring the post-boom comedown and relative dearth of megadeals witnessed across the globe. The reopening of the Chinese economy is being hotly anticipated as a much-needed spur to growth and will surely deliver more deal activity. APAC is an impressively dynamic regional economy and the relative strength of deal activity through the weaker H2 2022 holds promise for 2023. Learn more about the trends and top players driving deals across the region in this report.